Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Jana, Markova"'
Publikováno v:
Results in Engineering, Vol 23, Iss , Pp 102726- (2024)
Despite that the safety of cars is continuously increasing, improving the safety of road transportation remains a key issue of modern society. The design of suitable road restraint systems plays an important role. As the tests of barriers are technic
Externí odkaz:
https://doaj.org/article/d6f79a28a62643a4816785a08723683a
Publikováno v:
Acta Polytechnica CTU Proceedings, Vol 38, Pp 450-455 (2022)
The climatic data on which the current generation of the Eurocodes are based are mostly about 20 years old, with some exceptions of recent updates at a national level. The second generation of the Eurocodes for structural design is expected to be nat
Externí odkaz:
https://doaj.org/article/788d3c76fd47463dab3ac129d9a22e74
Publikováno v:
HemaSphere, Vol 7, p e60469b2 (2023)
Externí odkaz:
https://doaj.org/article/3b403be69c13441e99db7f13bfb40276
Autor:
Lubomira Novakova, Martin Gajdos, Jana Markova, Alice Martinkovicova, Zuzana Kosutzka, Jana Svantnerova, Peter Valkovic, Zsolt Csefalvay, Irena Rektorova
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
Parkinson’s disease (PD) affects the language processes, with a significant impact on the patients’ daily communication. We aimed to describe specific alterations in the comprehension of syntactically complex sentences in patients with PD (PwPD)
Externí odkaz:
https://doaj.org/article/0929e70de02d47ff855ce186426782ec
Autor:
Heidi Mocikova, Jana Markova, Lubica Gaherova, Maria Maco, Alice Sýkorová, David Belada, Marie Lukášová, Vit Prochazka, Juraj Duras, Tomas Kozak
Publikováno v:
HemaSphere, Vol 6, Pp 11-12 (2022)
Externí odkaz:
https://doaj.org/article/535d17014f5a43eb85eafc11ad9b2654
Autor:
Vit Prochazka, Heidi Mocikova, Alice Sykorova, Jana Markova, Marie Lukášová, Lubica Gaherova, Alexandra Kredatusova, Eva Kriegova, Maria Maco, Tomas Kozak, David Belada, Tomas Papajik
Publikováno v:
HemaSphere, Vol 6, Pp 21-21 (2022)
Externí odkaz:
https://doaj.org/article/1d9c54a116704f7d8c18c3786ca6f9f9
Autor:
Andreas Engert, Helen Goergen, Jana Markova, Thomas Pabst, Julia Meissner, Josée M. Zijlstra, Zdenek Král, Dennis A. Eichenauer, Martin Soekler, Richard Greil, Stefanie Kreissl, Ruth Scheuvens, Hans Eich, Carsten Kobe, Markus Dietlein, Harald Stein, Michael Fuchs, Volker Diehl, Peter Borchmann
Publikováno v:
HemaSphere, Vol 1, Iss 1 (2017)
Abstract. The international, randomized phase 3 HD15 trial established 6xeBEACOPP as standard therapy for patients with newly diagnosed advanced-stage Hodgkin lymphoma (HL) within the German Hodgkin Study Group (GHSG). We performed a follow-up analys
Externí odkaz:
https://doaj.org/article/5bbc60c61afa496f9b084c2273b060f5
Autor:
Trissevgeni Stavrakou, Maite Bauwens, Jana Markova, Katerina Sindelarova, Alex Guenther, Beata Opacka, Jean-François Müller
Publikováno v:
Atmospheric Chemistry and Physics, Vol 21, Pp 8413-8436 (2021)
Among the biogenic volatile organic compounds (BVOCs) emitted by plant foliage, isoprene is by far the most important in terms of both global emission and atmospheric impact. It is highly reactive in the air, and its degradation favours the generatio
Autor:
Claire Granier, Katerina Sindelarova, Peter Huszar, Jan Karlicky, Sabine Darras, Jana Markova, David Simpson
Biogenic volatile organic compounds (BVOCs) emitted from the terrestrial vegetation into the Earth’s atmosphere play an important role in atmospheric chemical processes. A gridded information of their temporal and spatial distribution is therefore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029a227bfe419e9d6c7eda9f0ada5837
https://doi.org/10.5194/essd-2021-226
https://doi.org/10.5194/essd-2021-226
Autor:
Peter Borchmann, Richard Greil, Volker Diehl, Josée M. Zijlstra, Jana Markova, Julia Meissner, Sarah Gillessen, Andreas Engert, Max S. Topp, Annette Plütschow, Dennis A. Eichenauer, Bastian von Tresckow, Michael Fuchs, Paul J Bröckelmann
Publikováno v:
Gillessen, S, Plütschow, A, Fuchs, M, Markova, J, Greil, R, Topp, M S, Meissner, J, Zijlstra, J M, Eichenauer, D A, Bröckelmann, P J, Diehl, V, Borchmann, P, Engert, A & von Tresckow, B 2021, ' Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14) ', The Lancet Haematology, vol. 8, no. 4, pp. e278-e288 . https://doi.org/10.1016/S2352-3026(21)00029-6
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group
Summary Background To improve the long-term tumour control in early, unfavourable Hodgkin Lymphoma, the German Hodgkin Study Group (GHSG) HD14 trial compared four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) with an intensifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cfeea8e46362c19db45e3507629e0b
https://research.vumc.nl/en/publications/c1e461ac-5125-4d24-8c7e-10b59a9ac174
https://research.vumc.nl/en/publications/c1e461ac-5125-4d24-8c7e-10b59a9ac174